Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
Jin Yong Kim, Oana Săndulescu, Liliana Preoțescu, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 8
Open Access | Times Cited: 21

Showing 21 citing articles:

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
Jon Salmanton‐García, Francesco Marchesi, María Gomes da Silva, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101939-101939
Open Access | Times Cited: 27
Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis
Karen M Elias, Shanchita R. Khan, Eva Stadler, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 5, pp. e459-e467
Open Access | Times Cited: 11
The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis
Shivani Singh, Simon Boyd, William HK Schilling, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 5, pp. 935-945
Open Access | Times Cited: 9
SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs
Sho Iketani, David D. Ho
Cell chemical biology (2024) Vol. 31, Iss. 4, pp. 632-657
Open Access | Times Cited: 9
Outpatient randomized controlled trials to reduce COVID‐19 hospitalization: Systematic review and meta‐analysis
David J. Sullivan, Daniele Focosi, Daniel F. Hanley, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Open Access | Times Cited: 21
Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial
Arvind Chopra, Girish Tillu, Kuldeep Chuadhary, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282688-e0282688
Open Access | Times Cited: 20
Outpatient regimens to reduce COVID-19 hospitalisations: a systematic review and meta-analysis of randomized controlled trials
David J. Sullivan, Daniele Focosi, Daniel F. Hanley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 16
Therapeutic developments for SARS-CoV-2 infection—Molecular mechanisms of action of antivirals and strategies for mitigating resistance in emerging variants in clinical practice
Oana Săndulescu, Cătălin Apostolescu, Liliana Preoțescu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 9
Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
Dario Akaberi, Monireh Pourghasemi Lati, Janina Krambrich, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 10
Open Access | Times Cited: 3
Clinical efficacy and safety of SARS-CoV-2-neutralizing monoclonal antibody in patients with COVID-19: A living systematic review and meta-analysis
Su‐Yeon Yu, Miyoung Choi, Chelim Cheong, et al.
Journal of Microbiology Immunology and Infection (2023) Vol. 56, Iss. 5, pp. 909-920
Open Access | Times Cited: 8
Interactions and Trends of Interleukins, PAI-1, CRP, and TNF-α in Inflammatory Responses during the Perioperative Period of Joint Arthroplasty: Implications for Pain Management—A Narrative Review
Arabela-Codruta Cocea, Cristian Ioan Stoica
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 537-537
Open Access | Times Cited: 2
Clinical efficacy of anti‐SARS‐CoV‐2 monoclonal antibodies in preventing hospitalisation and mortality among patients infected with Omicron variants: A systematic review and meta‐analysis
Danijela Miljanovic, Andja Ćirković, Ivana Lazarević, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 4
Closed Access | Times Cited: 6
COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants
Bill Thaddeus Padasas, Erica Españo, Sang‐Hyun Kim, et al.
Immune Network (2023) Vol. 23, Iss. 2
Open Access | Times Cited: 6
Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
Identification of unique and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
Dario Akaberi, Monireh Pourghasemi Lati, Janina Krambrich, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
In vitro and in vivo validation of the antiviral effect of hCypA against SARS-CoV-2 via binding to the RBD of spike protein
Woo-Ri Shin, Do Young ‍Kim, Sang Yong Kim, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1805-1816
Closed Access
Improved monoclonal antibody neutralization for Omicron sublineages BA.2.75, BF.7 and BQ.1
Krishna Khairnar, Ekant Tamboli, Lekha Salsekar, et al.
Authorea (Authorea) (2023)
Open Access
Efficacy and safety of regdanvimab in patients with mild to moderate COVID‐19: A rapid review and meta‐analysis
Behnam Amani, Bahman Amani
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 4, pp. 1282-1290
Open Access
Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea
Ji Yeon Lee, Seon Hee Bu, Eun-Hyang Song, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 10, pp. 2417-2435
Open Access
Antiviral drugs and vaccines currently used for COVID-19
Łukasz Dobrek
Farmacja Polska (2023) Vol. 79, Iss. 9, pp. 507-527
Open Access
The effect of etiopathogenetic therapy of COVID-19 on the severity of the disease: results of a multicenter double-blind placebo-controlled randomized trial
В. В. Никифоров, Vladimir A. Petrov, А.А. Стремоухов, et al.
Terapevticheskii arkhiv (2023) Vol. 95, Iss. 11, pp. 958-964
Open Access
Page 1

Scroll to top